Homeopathic Medicine :: Lachesis – Surukuku Snake Poison – Ophidia
Persons of a melancholy temperament, dark eyes, and a disposition to low spirits and indolence. Women of choleric temperament, with freckles and red hair (Phos.).
Headache
Homeopathic Medicine :: Adrenalin – Extract of Suprarenal bodies
Despondent and nervous; lack of interest in anything; no ambition; disinclination for mental work; absence of “grit.” Aversion to mental work, cannot concentrate thoughts.
Alternative Medicine :: Rural Elderly Turn to Alternative Remedies
Alternative medicine is just as popular in rural North Carolina as it is in America’s urban centers.
Fungal Infection :: New Treatment for Fungal Infections
The Food and Drug Administration approved Eraxis (anidulafungin) to treat certain infections caused by Candida, a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems.
Allergy :: First Generic Version of Flonase
The Food and Drug Administration (FDA) approved Fluticasone Propionate Nasal Spray, the first generic version of the brand name drug Flonase, giving American consumers an additional, lower cost alternative when choosing prescription drug products.
Depression :: Emsam – Selegiline as First Drug Patch for Depression
The Food and Drug Administration approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression. The once a day patch works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream. At its lowest strength, Emsam can be used without the dietary restrictions that are needed for all oral MAO inhibitors that are approved for treating major depression.
Epistaxis :: Homeopathy and epistaxis
It is commonly known as bleeding from the nose.
Constipation :: Amitiza, lubiprostone for treating chronic constipation
The FDA approved Amitiza (lubiprostone), the first drug of its chemical type, for the treatment of chronic constipation in the adult population where there is no known cause for the condition. The product will be available as capsules for use by adults to treat idiopathic constipation cases not caused by other diseases or by use of medications.
Heart Disease :: Ranexa, ranolazine – for treating chronic angina – chest pain
The Food and Drug Administration (FDA) announced the approval of Ranexa (ranolazine), a new drug for the treatment of chronic angina. Ranexa, a new molecular entity (NME), is the first drug approved to treat chronic angina in over ten years. Although several pharmacological activities of ranolazine have been described, the precise way the drug works is not fully understood. Because Ranexa affects electrical conduction in the heart (prolong the QT interval), it should only be used by patients who have not responded to other anti-anginal (long-acting nitrates, calcium channel blockers and beta blockers) drugs.
Influenza :: Tamiflu for Prevention of Influenza in Children
The U.S. Food & Drug Administration (FDA) approved the use of Tamiflu (oseltamivir phosphate) for prevention (prophylaxis) of seasonal influenza (“flu”) in children 1 to 12 years of age who had close contact with an infected individual. This is the first drug approved for prevention of both influenza A and B in pediatric patients.